Key Financial Inc’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-150
Closed -$2K 1177
2022
Q3
$2K Buy
+150
New +$1.74K ﹤0.01% 993

Key Financial Inc's AERI Position: Q4 2022 in Review

Key Financial Inc sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 150 shares — an estimated $2K sold.

Key Financial Inc first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Key Financial Inc reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Key Financial Inc sold 150 Aerie Pharmaceuticals shares in Q4 2022, an estimated $2K.
  • Key Financial Inc first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • Key Financial Inc's Aerie Pharmaceuticals position peaked at $2K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Key Financial Inc's 13F filing for Q4 2022, filed 26 Jan 2023.